RBC Capital analyst Joseph Spak downgrades Dana (NYSE:DAN) from Outperform to Sector Perform and raises the price target from $15 to $16.
Morgan Stanley Maintains Overweight on Corteva, Raises Price Target to $80
Morgan Stanley analyst Vincent Andrews maintains Corteva (NYSE:CTVA) with a Overweight and raises the price target from $70 to $80.